12:00 AM
Mar 29, 2010
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Movetis sales and marketing update

Movetis launched Resolor prucalopride in the U.K. to treat chronic constipation in women not receiving adequate relief from laxatives. The...

Read the full 86 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >